Considerations for Successful Scale-Up To Tox Batches And Phase-Api (Bulk Drugsubstance): LOJMS - Lupine Publishers

Considerations for Successful Scale-Up To Tox Batches And Phase-Api (Bulk Drugsubstance) by Krishna Sarma Pathy in LOJ Medical Sciences (LOJMS) in Lupine publishers

Practical Considerations in Pharmaceutical Production Scale-Up- This paper is meant to provide a high-level overview of the steps required to prepare the bulk drug substance API. From first-in-human and through each of the clinical trial stages and into commercialization, scale-up of formulation design is a natural part of pharmaceutical development. At each stage of process development, the batch size increases, from laboratory-scale batches that may be quite small to support preclinical and early clinical stages, to pilot batches that are used in process development, and finally to the production-scale batches needed to support commercialization Lupine publishers.

For more information click on below link

https://lupinepublishers.com/medical-science-journal/pdf/LOJMS.MS.ID.000112.pdf 
https://lupinepublishers.com/medical-science-journal/fulltext/considerations-for-successful-scale-up-to-tox-batches-and-phase-api.ID.000112.php
https://lupinepublishers.com/medical-science-journal/abstracts/considerations-for-successful-scale-up-to-tox-batches-and-phase-api.ID.000112.php

For more Lupine publishers open access journals click the below link
https://www.lupinepublishers.com/

For more medical sciences articles click the below link
https://www.lupinepublishers.com/medical-science-journal/